Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Fly Intel: Top five analyst downgrades » 09:54
05/14/21
05/14
09:54
05/14/21
09:54
EXR

Extra Space Storage

$143.95 /

-1.19 (-0.82%)

, LITE

Lumentum

$66.50 /

-0.965 (-1.43%)

, BLFS

BioLife Solutions

$28.78 /

-0.65 (-2.21%)

, ACB

Aurora Cannabis

$6.74 /

-0.62 (-8.43%)

, SFFYF

Signify NV

$61.75 /

+ (+0.00%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Extra Space Storage (EXR) downgraded to Market Perform from Outperform at BMO Capital with analyst Juan Sanabria citing valuation for the downgrade with the stock up 24% in the past three months. 2. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying Lumentum can participate in the "robust" growth in Ttlecom optical components, as well as long-term growth opportunities in Automotive LiDAR, but in the meantime, the company faces headwinds in the near term from moderating 5G infrastructure-led demand in China as well as in the near to medium term from moderating growth opportunities in the 3D sensing markets for smartphones. 3. BioLife Solutions (BLFS) downgraded to Hold from Buy at Benchmark with analyst Robert Wasserman noting that other bioprocessing stocks have sold off this spring and citing relative valuation for his downgrade. 4. Aurora Cannabis (ACB) downgraded to Sell from Hold at Canaccord with analyst Matt Bottomley saying Aurora's Q3 earnings came in significantly behind estimates as the company's adult-use sales in Canada continue to fall at an accelerated pace. 5. Signify NV (SFFYF) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Daniela Costa saying she sees limited near-term catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
LITE Lumentum
$66.50 /

-0.965 (-1.43%)

EXR Extra Space Storage
$143.95 /

-1.19 (-0.82%)

BLFS BioLife Solutions
$28.78 /

-0.65 (-2.21%)

ACB Aurora Cannabis
$6.74 /

-0.62 (-8.43%)

EXR Extra Space Storage
$143.95 /

-1.19 (-0.82%)

05/14/21 BMO Capital
Extra Space Storage downgraded to Market Perform from Outperform at BMO Capital
03/30/21 KeyBanc
Extra Space Storage price target raised to $142 from $134 at KeyBanc
03/29/21 Wells Fargo
Extra Space Storage price target raised to $147 from $125 at Wells Fargo
03/05/21 Truist
Extra Space Storage price target raised to $137 from $125 at Truist
LITE Lumentum
$66.50 /

-0.965 (-1.43%)

05/14/21 JPMorgan
Lumentum resumed with Neutral from Overweight at JPMorgan
05/13/21
Fly Intel: Top five analyst downgrades
05/13/21 DA Davidson
Lumentum price target lowered to $95 from $110 at DA Davidson
05/13/21 Needham
Lumentum price target lowered to $87 from $123 at Needham
BLFS BioLife Solutions
$28.78 /

-0.65 (-2.21%)

05/14/21 Benchmark
BioLife Solutions downgraded to Hold from Buy at Benchmark
03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
ACB Aurora Cannabis
$6.74 /

-0.62 (-8.43%)

05/14/21 Canaccord
Aurora Cannabis downgraded to Sell from Hold at Canaccord
05/14/21 BMO Capital
Aurora Cannabis upgraded to Market Perform from Underperform at BMO Capital
05/14/21 BMO Capital
Aurora Cannabis upgraded to Market Perform from Underperform at BMO Capital
05/11/21 CIBC
Aurora Cannabis downgraded to Underperformer from Neutral at CIBC
SFFYF Signify NV
$61.75 /

+ (+0.00%)

05/13/21 Goldman Sachs
Signify NV downgraded to Buy from Conviction Buy at Goldman Sachs
05/05/21 ING Bank
Signify NV upgraded to Buy from Hold at ING Bank
04/07/21 Morgan Stanley
Signify NV price target raised to EUR 29 from EUR 28 at Morgan Stanley
10/26/20 Citi
Signify NV price target raised to EUR 40 at Citi
LITE Lumentum
$66.50 /

-0.965 (-1.43%)

EXR Extra Space Storage
$143.95 /

-1.19 (-0.82%)

BLFS BioLife Solutions
$28.78 /

-0.65 (-2.21%)

ACB Aurora Cannabis
$6.74 /

-0.62 (-8.43%)

  • 19
    Mar
  • 22
    Jan
  • 11
    Nov
  • 02
    Jul
LITE Lumentum
$66.50 /

-0.965 (-1.43%)

ACB Aurora Cannabis
$6.74 /

-0.62 (-8.43%)

LITE Lumentum
$66.50 /

-0.965 (-1.43%)

EXR Extra Space Storage
$143.95 /

-1.19 (-0.82%)

BLFS BioLife Solutions
$28.78 /

-0.65 (-2.21%)

ACB Aurora Cannabis
$6.74 /

-0.62 (-8.43%)

LITE Lumentum
$66.50 /

-0.965 (-1.43%)

EXR Extra Space Storage
$143.95 /

-1.19 (-0.82%)

ACB Aurora Cannabis
$6.74 /

-0.62 (-8.43%)

Downgrade
BioLife Solutions downgraded to Hold from Buy at Benchmark » 06:28
05/14/21
05/14
06:28
05/14/21
06:28
BLFS

BioLife Solutions

$29.46 /

-0.845 (-2.79%)

Benchmark analyst Robert…

Benchmark analyst Robert Wasserman downgraded BioLife Solutions to Hold from Buy with no price target. Noting that other bioprocessing stocks have sold off this spring, Wasserman cites relative valuation for his downgrade. He is also "somewhat cautious" about potential dilution from BioLife's recently closed Stirling Ultracold acquisition, Wasserman added.

ShowHide Related Items >><<
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

  • 02
    Jul
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

Earnings
BioLife Solutions sees 2021 revenue $106M-$115M, consensus $105.65M  16:19
05/13/21
05/13
16:19
05/13/21
16:19
BLFS

BioLife Solutions

$29.46 /

-0.845 (-2.79%)

 
ShowHide Related Items >><<
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

  • 02
    Jul
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

Earnings
BioLife Solutions reports Q1 non-GAAP EPS 1c, consensus (4c) » 16:18
05/13/21
05/13
16:18
05/13/21
16:18
BLFS

BioLife Solutions

$29.46 /

-0.845 (-2.79%)

Reports Q1 revenue…

Reports Q1 revenue $16.8M, consensus $16.05M. CEO Mike Rice commented, "The entire BioLife team contributed to across-the-board excellent performance with total revenue reaching a record $16.8M. We gained 80 new customers in Q1 alone, compared with our stellar addition of 213 customers for FY20. We achieved record revenue from our media franchise as we gained 16 new media customers and received confirmation that our media will be used in an additional 13 customer clinical trials. (...) We expect our acquisition of Global Cooling will drive significant top-line growth in 2021," he added. "The combination of Stirling Ultracold and our recently launched high-capacity controlled rate freezer products opens new opportunities, as we now compete for the entire range of controlled temperature storage solutions. We expanded our leadership since the beginning of 2021, including welcoming former Stirling CEO, Dusty Tenney, as president and COO," said Mr. Rice. "We also named new leaders of our sales and human resources teams and added two new highly qualified board members to help guide our acquisition and integration strategies. In summary, we're configured to deliver transformational results in 2021".

ShowHide Related Items >><<
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

  • 02
    Jul
BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

Hot Stocks
BioLife Solutions: Stirling expands partnership with leading CDMO » 16:36
05/03/21
05/03
16:36
05/03/21
16:36
BLFS

BioLife Solutions

$35.04 /

+0.19 (+0.55%)

BioLife announced that…

BioLife announced that Stirling has expanded its existing partnership with a leading global contract development and manufacturing organization and has been selected by this customer as their preferred provider of ULT storage across their multiple business units. Stirling will supply approximately 100 energy-efficient ULT mechanical freezers to support this customer's cold chain capabilities for biologics and emerging modalities. This augments the existing installed base of 200 Stirling freezers across this CDMO's worldwide facilities footprint.

ShowHide Related Items >><<
BLFS BioLife Solutions
$35.04 /

+0.19 (+0.55%)

BLFS BioLife Solutions
$35.04 /

+0.19 (+0.55%)

03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
BLFS BioLife Solutions
$35.04 /

+0.19 (+0.55%)

  • 02
    Jul
BLFS BioLife Solutions
$35.04 /

+0.19 (+0.55%)

Over a quarter ago
Recommendations
BioLife Solutions price target raised to $61 from $35.50 at B. Riley » 08:00
03/24/21
03/24
08:00
03/24/21
08:00
BLFS

BioLife Solutions

$41.80 /

+3.28 (+8.52%)

B. Riley Securities…

B. Riley Securities analyst Marc Wiesenberger raised the firm's price target on BioLife Solutions to $61 from $35.50 and reiterates a Buy rating on the shares. The company's Q4 results topped estimates but were overshadowed by the concurrent announcement that it is acquiring privately-held, ultra-low temperature mechanical freezer manufacturer Stirling Ultracold in an all-stock deal worth $255M, Wiesenberger tells investors in a research note. Stirling is expected to push BioLife's revenue above the key $100M revenue mark in fiscal 2021, says the analyst. He believes there are a number of benefits including manufacturing synergies and cross-selling opportunities that should outweigh the near-term margin compression.

ShowHide Related Items >><<
BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
03/23/21 Stephens
BioLife Solutions price target raised to $55 from $50 at Stephens
BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

  • 02
    Jul
BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:34
03/23/21
03/23
16:34
03/23/21
16:34
PFE

Pfizer

$35.36 /

-0.635 (-1.76%)

, HIG

Hartford Financial

$67.36 /

+0.02 (+0.03%)

, CB

Chubb

$157.35 /

+0.2 (+0.13%)

, JNJ

Johnson & Johnson

$160.40 /

-0.14 (-0.09%)

, CTLT

Catalent

$107.45 /

-2.53 (-2.30%)

, AMC

AMC Entertainment

$10.66 /

-1.79 (-14.38%)

, CNK

Cinemark

$20.73 /

-1.645 (-7.35%)

, CNNWF

Cineworld Group

$0.00 /

+ (+0.00%)

, IMAX

Imax

$20.18 /

-0.86 (-4.09%)

, MCS

Marcus

$19.63 /

-1.765 (-8.25%)

, NCMI

National CineMedia

$4.74 /

-0.28 (-5.58%)

, DIS

Disney

$188.87 /

-3.99 (-2.07%)

, ORMP

Oramed

$10.99 /

+0.59 (+5.67%)

, BLFS

BioLife Solutions

$41.80 /

+3.28 (+8.52%)

, FREQ

Frequency Therapeutics

$8.00 /

-28.285 (-77.96%)

, IONS

Ionis Pharmaceuticals

$43.61 /

-12.02 (-21.61%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Wall Street had a down…

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.36 /

-0.635 (-1.76%)

ORMP Oramed
$10.99 /

+0.59 (+5.67%)

NCMI National CineMedia
$4.74 /

-0.28 (-5.58%)

JNJ Johnson & Johnson
$160.40 /

-0.14 (-0.09%)

IONS Ionis Pharmaceuticals
$43.61 /

-12.02 (-21.61%)

IMAX Imax
$20.18 /

-0.86 (-4.09%)

HIG Hartford Financial
$67.36 /

+0.02 (+0.03%)

FREQ Frequency Therapeutics
$8.00 /

-28.285 (-77.96%)

DIS Disney
$188.87 /

-3.99 (-2.07%)

CTLT Catalent
$107.45 /

-2.53 (-2.30%)

CNNWF Cineworld Group
$0.00 /

+ (+0.00%)

CNK Cinemark
$20.73 /

-1.645 (-7.35%)

BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

AMC AMC Entertainment
$10.66 /

-1.79 (-14.38%)

PFE Pfizer
$35.36 /

-0.635 (-1.76%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
HIG Hartford Financial
$67.36 /

+0.02 (+0.03%)

03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/24/21 Barclays
Hartford Financial price target raised to $73 from $55 at Barclays
03/19/21 Raymond James
Hartford holders may approve deal in $75-$85 share range, says Raymond James
03/19/21
Fly Intel: Top five analyst downgrades
CB Chubb
$157.35 /

+0.2 (+0.13%)

03/19/21 Evercore ISI
Hartford Financial price target raised to $70 from $64 at Evercore ISI
JNJ Johnson & Johnson
$160.40 /

-0.14 (-0.09%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
CTLT Catalent
$107.45 /

-2.53 (-2.30%)

03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
01/08/21 JPMorgan
Catalent price target raised to $130 from $110 at JPMorgan
AMC AMC Entertainment
$10.66 /

-1.79 (-14.38%)

03/16/21 Citi
Citi keeps $2 target on AMC Entertainment, says shares overvalued
03/11/21 B. Riley
AMC Entertainment price target raised to $7 from $5.50 at B. Riley Securities
03/10/21 LightShed Partners
AMC Entertainment initiated with a Sell at LightShed Partners
02/04/21 Citi
Citi sees 'dramatically reduced' bankruptcy risk for AMC Entertainment
CNK Cinemark
$20.73 /

-1.645 (-7.35%)

03/24/21 B. Riley
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
03/03/21 Barrington
Cinemark price target raised to $26 from $22 at Barrington
03/03/21 Benchmark
Cinemark price target raised to $30 from $21 at Benchmark
02/23/21 Wedbush
Cinemark price target raised to $28 from $15 at Wedbush
CNNWF Cineworld Group
$0.00 /

+ (+0.00%)

03/23/21 Peel Hunt
Cineworld Group downgraded to Hold from Buy at Peel Hunt
01/08/21 Morgan Stanley
Cineworld Group price target lowered to 40 GBp from 45 GBp at Morgan Stanley
12/08/20 Jefferies
Cineworld Group price target raised to 110 GBp from 40 GBp at Jefferies
11/24/20 JPMorgan
Cineworld Group price target raised to 50 GBp from 35 GBp at JPMorgan
IMAX Imax
$20.18 /

-0.86 (-4.09%)

03/09/21 Barrington
Imax price target raised to $27 from $25 at Barrington
03/05/21 Macquarie
Imax price target raised to $25 after Q4 earnings beat at Macquarie
03/05/21 Benchmark
Imax price target raised to $24 from $22 at Benchmark
MCS Marcus
$19.63 /

-1.765 (-8.25%)

03/09/21 Barrington
Marcus price target raised to $25 from $19 at Barrington
01/26/21 B. Riley
Marcus price target raised to $25 from $19 at B. Riley Securities
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
NCMI National CineMedia
$4.74 /

-0.28 (-5.58%)

01/26/21 B. Riley
National CineMedia price target raised to $6 from $4.50 at B. Riley Securities
12/28/20 B. Riley
'Wonder Women' opens well above expectations, says B. Riley Securities
12/04/20 B. Riley
Theater selloff on Warner Bros. news likely an overreaction, says B. Riley
DIS Disney
$188.87 /

-3.99 (-2.07%)

03/23/21 Macquarie
Disney 'realtive winner' from NFL rights deals, says Macquarie
03/18/21 JPMorgan
Disney's parks will emerge stronger post-pandemic, says JPMorgan
03/12/21 Needham
Netflix shares can fall 50% if growth cred is lost, says Needham
ORMP Oramed
$10.99 /

+0.59 (+5.67%)

12/03/20 Alliance Global Partners
Oramed initiated with a Buy at Alliance Global Partners
07/13/20 H.C. Wainwright
Oramed price target raised to $17 from $16 at H.C. Wainwright
06/22/20 H.C. Wainwright
Oramed price target lowered to $16 from $20 at H.C. Wainwright
BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
FREQ Frequency Therapeutics
$8.00 /

-28.285 (-77.96%)

03/24/21 B. Riley
Frequency Therapeutics price target lowered to $35 from $79 at B. Riley
03/24/21 Oppenheimer
Frequency Therapeutics price target lowered to $20 from $68 at Oppenheimer
02/11/21 Oppenheimer
Frequency Therapeutics price target raised to $68 from $48 at Oppenheimer
01/27/21
Fly Intel: Top five analyst upgrades
IONS Ionis Pharmaceuticals
$43.61 /

-12.02 (-21.61%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
03/23/21 Cowen
Ionis Pharmaceuticals HD program halt removes overhang, says Cowen
03/23/21 Morgan Stanley
Ionis Pharmaceuticals price target lowered to $43 from $50 at Morgan Stanley
RHHBY Roche
$0.00 /

+ (+0.00%)

03/23/21 RBC Capital
Ionis Pharmaceuticals price target lowered to $65 from $76 at RBC Capital
RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.36 /

-0.635 (-1.76%)

ORMP Oramed
$10.99 /

+0.59 (+5.67%)

NCMI National CineMedia
$4.74 /

-0.28 (-5.58%)

MCS Marcus
$19.63 /

-1.765 (-8.25%)

JNJ Johnson & Johnson
$160.40 /

-0.14 (-0.09%)

IONS Ionis Pharmaceuticals
$43.61 /

-12.02 (-21.61%)

IMAX Imax
$20.18 /

-0.86 (-4.09%)

HIG Hartford Financial
$67.36 /

+0.02 (+0.03%)

FREQ Frequency Therapeutics
$8.00 /

-28.285 (-77.96%)

DIS Disney
$188.87 /

-3.99 (-2.07%)

CTLT Catalent
$107.45 /

-2.53 (-2.30%)

CNK Cinemark
$20.73 /

-1.645 (-7.35%)

CB Chubb
$157.35 /

+0.2 (+0.13%)

BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

AMC AMC Entertainment
$10.66 /

-1.79 (-14.38%)

  • 23
    Nov
  • 02
    Jul
  • 11
    Jun
RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.36 /

-0.635 (-1.76%)

JNJ Johnson & Johnson
$160.40 /

-0.14 (-0.09%)

HIG Hartford Financial
$67.36 /

+0.02 (+0.03%)

DIS Disney
$188.87 /

-3.99 (-2.07%)

CNNWF Cineworld Group
$0.00 /

+ (+0.00%)

CB Chubb
$157.35 /

+0.2 (+0.13%)

AMC AMC Entertainment
$10.66 /

-1.79 (-14.38%)

PFE Pfizer
$35.36 /

-0.635 (-1.76%)

ORMP Oramed
$10.99 /

+0.59 (+5.67%)

NCMI National CineMedia
$4.74 /

-0.28 (-5.58%)

MCS Marcus
$19.63 /

-1.765 (-8.25%)

JNJ Johnson & Johnson
$160.40 /

-0.14 (-0.09%)

IONS Ionis Pharmaceuticals
$43.61 /

-12.02 (-21.61%)

IMAX Imax
$20.18 /

-0.86 (-4.09%)

HIG Hartford Financial
$67.36 /

+0.02 (+0.03%)

FREQ Frequency Therapeutics
$8.00 /

-28.285 (-77.96%)

DIS Disney
$188.87 /

-3.99 (-2.07%)

CTLT Catalent
$107.45 /

-2.53 (-2.30%)

CNNWF Cineworld Group
$0.00 /

+ (+0.00%)

CNK Cinemark
$20.73 /

-1.645 (-7.35%)

CB Chubb
$157.35 /

+0.2 (+0.13%)

BLFS BioLife Solutions
$41.80 /

+3.28 (+8.52%)

AMC AMC Entertainment
$10.66 /

-1.79 (-14.38%)

PFE Pfizer
$35.36 /

-0.635 (-1.76%)

ORMP Oramed
$10.99 /

+0.59 (+5.67%)

JNJ Johnson & Johnson
$160.40 /

-0.14 (-0.09%)

IMAX Imax
$20.18 /

-0.86 (-4.09%)

DIS Disney
$188.87 /

-3.99 (-2.07%)

CNK Cinemark
$20.73 /

-1.645 (-7.35%)

CB Chubb
$157.35 /

+0.2 (+0.13%)

AMC AMC Entertainment
$10.66 /

-1.79 (-14.38%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:00
03/23/21
03/23
12:00
03/23/21
12:00
AZN

AstraZeneca

$49.70 /

-1.51 (-2.95%)

, PFE

Pfizer

$35.55 /

-0.45 (-1.25%)

, HIG

Hartford Financial

$66.10 /

-1.24 (-1.84%)

, CB

Chubb

$157.70 /

+0.55 (+0.35%)

, ORMP

Oramed

$10.98 /

+0.58 (+5.58%)

, BLFS

BioLife Solutions

$41.96 /

+3.44 (+8.93%)

, FREQ

Frequency Therapeutics

$8.85 /

-27.43 (-75.61%)

, IONS

Ionis Pharmaceuticals

$45.37 /

-10.26 (-18.44%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

The major averages are…

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.55 /

-0.45 (-1.25%)

ORMP Oramed
$10.98 /

+0.58 (+5.58%)

IONS Ionis Pharmaceuticals
$45.37 /

-10.26 (-18.44%)

HIG Hartford Financial
$66.10 /

-1.24 (-1.84%)

FREQ Frequency Therapeutics
$8.85 /

-27.43 (-75.61%)

BLFS BioLife Solutions
$41.96 /

+3.44 (+8.93%)

AZN AstraZeneca
$49.70 /

-1.51 (-2.95%)

AZN AstraZeneca
$49.70 /

-1.51 (-2.95%)

03/23/21 Societe Generale
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Societe Generale
03/18/21 Deutsche Bank
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 Jefferies
AstraZeneca upgraded to Buy from Hold at Jefferies
PFE Pfizer
$35.55 /

-0.45 (-1.25%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
HIG Hartford Financial
$66.10 /

-1.24 (-1.84%)

03/19/21 Raymond James
Hartford holders may approve deal in $75-$85 share range, says Raymond James
03/19/21
Fly Intel: Top five analyst downgrades
03/19/21
Fly Intel: Top five analyst upgrades
03/19/21 Evercore ISI
Hartford Financial price target raised to $70 from $64 at Evercore ISI
CB Chubb
$157.70 /

+0.55 (+0.35%)

03/19/21 MKM Partners
Hartford Financial downgraded to Neutral from Buy at MKM Partners
03/19/21 Wells Fargo
Hartford Financial price target raised to $73 from $60 at Wells Fargo
ORMP Oramed
$10.98 /

+0.58 (+5.58%)

12/03/20 Alliance Global Partners
Oramed initiated with a Buy at Alliance Global Partners
07/13/20 H.C. Wainwright
Oramed price target raised to $17 from $16 at H.C. Wainwright
06/22/20 H.C. Wainwright
Oramed price target lowered to $16 from $20 at H.C. Wainwright
BLFS BioLife Solutions
$41.96 /

+3.44 (+8.93%)

03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
03/23/21 Stephens
BioLife Solutions price target raised to $55 from $50 at Stephens
FREQ Frequency Therapeutics
$8.85 /

-27.43 (-75.61%)

02/11/21 Oppenheimer
Frequency Therapeutics price target raised to $68 from $48 at Oppenheimer
01/27/21
Fly Intel: Top five analyst upgrades
01/27/21 JPMorgan
JPMorgan upgrades Frequency Therapeutics ahead of 'transformational' data
01/27/21 JPMorgan
Frequency Therapeutics upgraded to Overweight from Neutral at JPMorgan
IONS Ionis Pharmaceuticals
$45.37 /

-10.26 (-18.44%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
03/23/21 Cowen
Ionis Pharmaceuticals HD program halt removes overhang, says Cowen
03/23/21 Morgan Stanley
Ionis Pharmaceuticals price target lowered to $43 from $50 at Morgan Stanley
RHHBY Roche
$0.00 /

+ (+0.00%)

03/23/21 RBC Capital
Ionis Pharmaceuticals price target lowered to $65 from $76 at RBC Capital
RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.55 /

-0.45 (-1.25%)

ORMP Oramed
$10.98 /

+0.58 (+5.58%)

IONS Ionis Pharmaceuticals
$45.37 /

-10.26 (-18.44%)

HIG Hartford Financial
$66.10 /

-1.24 (-1.84%)

FREQ Frequency Therapeutics
$8.85 /

-27.43 (-75.61%)

CB Chubb
$157.70 /

+0.55 (+0.35%)

BLFS BioLife Solutions
$41.96 /

+3.44 (+8.93%)

AZN AstraZeneca
$49.70 /

-1.51 (-2.95%)

  • 02
    Jul
RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.55 /

-0.45 (-1.25%)

HIG Hartford Financial
$66.10 /

-1.24 (-1.84%)

CB Chubb
$157.70 /

+0.55 (+0.35%)

AZN AstraZeneca
$49.70 /

-1.51 (-2.95%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.55 /

-0.45 (-1.25%)

ORMP Oramed
$10.98 /

+0.58 (+5.58%)

IONS Ionis Pharmaceuticals
$45.37 /

-10.26 (-18.44%)

FREQ Frequency Therapeutics
$8.85 /

-27.43 (-75.61%)

CB Chubb
$157.70 /

+0.55 (+0.35%)

BLFS BioLife Solutions
$41.96 /

+3.44 (+8.93%)

AZN AstraZeneca
$49.70 /

-1.51 (-2.95%)

PFE Pfizer
$35.55 /

-0.45 (-1.25%)

ORMP Oramed
$10.98 /

+0.58 (+5.58%)

CB Chubb
$157.70 /

+0.55 (+0.35%)

AZN AstraZeneca
$49.70 /

-1.51 (-2.95%)

On The Fly
Fly Intel: Pre-market Movers » 08:56
03/23/21
03/23
08:56
03/23/21
08:56
EHTH

eHealth

$68.17 /

+3.13 (+4.81%)

, BLFS

BioLife Solutions

$38.52 /

-0.33 (-0.85%)

, ORMP

Oramed

$10.40 /

+1.24 (+13.54%)

, FREQ

Frequency Therapeutics

$36.28 /

+1.99 (+5.80%)

, IONS

Ionis Pharmaceuticals

$55.63 /

+1.39 (+2.56%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, MP

MP Materials

$45.20 /

-0.79 (-1.72%)

, QS

QuantumScape

$64.19 /

+4.93 (+8.32%)

, CHMA

Chiasma

$3.44 /

+0.035 (+1.03%)

Check out this morning's…

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

ORMP Oramed
$10.40 /

+1.24 (+13.54%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

FREQ Frequency Therapeutics
$36.28 /

+1.99 (+5.80%)

EHTH eHealth
$68.17 /

+3.13 (+4.81%)

CHMA Chiasma
$3.44 /

+0.035 (+1.03%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

EHTH eHealth
$68.17 /

+3.13 (+4.81%)

03/23/21 Credit Suisse
eHealth price target raised to $78 from $63 at Credit Suisse
03/23/21 Evercore ISI
eHealth price target raised to $80 from $60 at Evercore ISI
02/19/21
Fly Intel: Top five analyst downgrades
02/19/21 Deutsche Bank
eHealth downgraded to Hold on 'credibility gap' at Deutsche Bank
BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
03/23/21 Stephens
BioLife Solutions price target raised to $55 from $50 at Stephens
ORMP Oramed
$10.40 /

+1.24 (+13.54%)

12/03/20 Alliance Global Partners
Oramed initiated with a Buy at Alliance Global Partners
07/13/20 H.C. Wainwright
Oramed price target raised to $17 from $16 at H.C. Wainwright
06/22/20 H.C. Wainwright
Oramed price target lowered to $16 from $20 at H.C. Wainwright
FREQ Frequency Therapeutics
$36.28 /

+1.99 (+5.80%)

02/11/21 Oppenheimer
Frequency Therapeutics price target raised to $68 from $48 at Oppenheimer
01/27/21
Fly Intel: Top five analyst upgrades
01/27/21 JPMorgan
JPMorgan upgrades Frequency Therapeutics ahead of 'transformational' data
01/27/21 JPMorgan
Frequency Therapeutics upgraded to Overweight from Neutral at JPMorgan
IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
03/23/21 Cowen
Ionis Pharmaceuticals HD program halt removes overhang, says Cowen
03/23/21 Morgan Stanley
Ionis Pharmaceuticals price target lowered to $43 from $50 at Morgan Stanley
03/23/21 Barclays
Ionis Pharmaceuticals price target lowered to $47 from $52 at Barclays
RHHBY Roche
$0.00 /

+ (+0.00%)

03/23/21 RBC Capital
Ionis Pharmaceuticals price target lowered to $65 from $76 at RBC Capital
03/17/21 BTIG
GenMark downgraded to Neutral from Buy at BTIG
MP MP Materials
$45.20 /

-0.79 (-1.72%)

03/10/21 Cowen
MP Materials initiated with an Outperform at Cowen
03/09/21 Deutsche Bank
MP Materials downgraded to Hold on valuation at Deutsche Bank
03/08/21 Deutsche Bank
MP Materials downgraded to Hold from Buy at Deutsche Bank
03/02/21
Fly Intel: Top five analyst initiations
QS QuantumScape
$64.19 /

+4.93 (+8.32%)

03/08/21 Cowen
Cowen bullish on battery technology, starts QuantumScape at Outperform
03/08/21 Cowen
QuantumScape initiated with an Outperform at Cowen
03/04/21 Baird
QuantumScape initiated with a Neutral at Baird
02/11/21 Morgan Stanley
QuantumScape initiated with an Overweight at Morgan Stanley
CHMA Chiasma
$3.44 /

+0.035 (+1.03%)

03/02/21 H.C. Wainwright
Chiasma price target raised to $12 from $10 at H.C. Wainwright
01/11/21 Piper Sandler
Chiasma price target lowered to $15 from $19 at Piper Sandler
11/05/20 Piper Sandler
Chiasma reports first Mycapssa sales, strong cash balance, says Piper Sandler
08/31/20 Piper Sandler
Piper sees strong demand for Chiasma's oral acromegaly therapy
RHHBY Roche
$0.00 /

+ (+0.00%)

ORMP Oramed
$10.40 /

+1.24 (+13.54%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

FREQ Frequency Therapeutics
$36.28 /

+1.99 (+5.80%)

EHTH eHealth
$68.17 /

+3.13 (+4.81%)

CHMA Chiasma
$3.44 /

+0.035 (+1.03%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

  • 25
    Mar
  • 24
    Mar
  • 02
    Jul
  • 01
    Jul
RHHBY Roche
$0.00 /

+ (+0.00%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

FREQ Frequency Therapeutics
$36.28 /

+1.99 (+5.80%)

EHTH eHealth
$68.17 /

+3.13 (+4.81%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

ORMP Oramed
$10.40 /

+1.24 (+13.54%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

EHTH eHealth
$68.17 /

+3.13 (+4.81%)

Recommendations
BioLife Solutions price target raised to $60 from $40 at Maxim » 08:21
03/23/21
03/23
08:21
03/23/21
08:21
BLFS

BioLife Solutions

$38.52 /

-0.33 (-0.85%)

Maxim analyst Jason…

Maxim analyst Jason McCarthy raised the firm's price target on BioLife Solutions to $60 from $40 and keeps a Buy rating on the shares. The analyst cites the company's Q4 revenue growth driven by the biopreservation media sales and the addition of SciSafe biostorage revenue. McCarthy adds that M&A remains a priority for BioLife, and its acquisition of Stirling Ultracold brings in mechanical freezing systems capable of storing in the -20 degrees C to -86degrees C range, which offers "significant growth potential" considering that the COVID vaccines with cold temperature requirements are just the first mRNA vaccines to get approval.

ShowHide Related Items >><<
BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland
03/23/21 Stephens
BioLife Solutions price target raised to $55 from $50 at Stephens
03/23/21 Benchmark
BioLife Solutions upgraded to Buy at Benchmark after Stirling Ultracold deal
BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

  • 02
    Jul
BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.